The UNCLCN Telehealth Annual Survey is currently open! We are seeking your feedback for the 2026 Telehealth Webinar series.
Tell us your continuing healthcare education needs!
Welcome to the UNCLCN Learning Portal
The UNCLCN Learning Portal contains oncology education videos presented by experts in North Carolina and throughout the US.
View our Live Webinars and Self-Paced Online Courses to earn free continuing education credit!
Free Continuing Education credits are available for:
Physicians, Nurses, Pharmacists, Pharmacy Technicians, Radiologic Technologists, and Oncology Data Specialists
Upcoming Live Webinar
|
Featured Self-Paced Online Course
![]() |
Patient Centered Care NCPD/CNE • ACPE • ASRT Denise Spector, PhD, MPH, MSN, ANP, FAIHM View More Self-Paced, Online Courses |
Ready to Learn!
Please take a look at all our educational offerings. Continuing Education credits are available for healthcare providers in select webinars.
![]() | Live Webinars |
![]() | Self-Paced Online Courses |
![]() | All Webinars |
![]() | More about us |
Sign up for our newsletter or follow us on social media!
![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
Recent Courses
Immunotherapy has made tremendous progress as cancer-directed therapy has evolved, particularly in the field of T cell-engaging therapies. Common and serious side effects of these types of therapies include Cytokine Release Syndrome (CRS) and Immune Effector Cell-Associated Neurotoxicity Syndrome (ICANS). Join us as Bejal Kikani, MSN, FNP-BC, WHNP-BC, discusses the recognition, grading, and treatment of these toxicities.
|
Jeremiah 'Jig' Deneve, DO, FACS, provides an overview of the natural history, treatment, and outcome for peritoneal carcinomatosis.
|
Megan McElfresh, PA-C, will review chimeric antigen receptor therapy, associated side effects, and the treatment or prevention of side effects.
|
Embracing Indigenous Wisdom in Evidence Based Cancer Prevention: A Path of Collaboration, Respect, and Insight on Duke’s Voyage” is a presentation that explores the partnership between modern scientific research and indigenous wisdom in the pursuit of effective cancer prevention strategies. It underscores the humility in learning from indigenous knowledge, and the discovery of insights that can enhance evidence-based approaches to cancer prevention.
|
Puneet Singh Jolly, MD, PhD discusses keratinocyte neoplasms are by far the most common malignancy in the world. While surgical treatments remain the most common and most effective therapy, there are numerous emerging non-surgical techniques. We discuss these and the rationale for using such treatments, particularly in specific challenging clinical scenarios.
|
Hung-Jui Tan, MD, MSHPM, will review recent practice-changing research and new management recommendations for patients with prostate, kidney, bladder, and testicular cancer.
|